BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25411806)

  • 1. Demographic features and natural history of intermediate-risk multifocal versus unifocal intraductal papillary mucinous neoplasms.
    Rosenblatt R; Dorfman V; Epelboym I; Poneros JM; Sethi A; Lightdale C; Woo Y; Gress FG; Allendorf JD; Schrope BA; Chabot JA; Gonda TA
    Pancreas; 2015 Apr; 44(3):478-83. PubMed ID: 25411806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.
    Nguyen AH; Toste PA; Farrell JJ; Clerkin BM; Williams J; Muthusamy VR; Watson RR; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
    J Gastrointest Surg; 2015 Feb; 19(2):258-65. PubMed ID: 25373706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
    Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
    Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms.
    Kayal M; Luk L; Hecht EM; Do C; Schrope BA; Chabot JA; Gonda TA
    AJR Am J Roentgenol; 2017 Aug; 209(2):320-326. PubMed ID: 28590817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic lesions and intraductal neoplasms of the pancreas.
    Fasanella KE; McGrath K
    Best Pract Res Clin Gastroenterol; 2009; 23(1):35-48. PubMed ID: 19258185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.
    Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M
    Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Progression Among Low-Risk Intraductal Papillary Mucinous Neoplasms in a Multicenter Surveillance Cohort.
    Gausman V; Kandel P; Van Riet PA; Moris M; Kayal M; Do C; Poneros JM; Sethi A; Gress FG; Schrope BA; Luk L; Hecht E; Jovani M; Bruno MJ; Cahen DL; Wallace MB; Gonda TA
    Pancreas; 2018 Apr; 47(4):471-476. PubMed ID: 29521942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural language processing for the development of a clinical registry: a validation study in intraductal papillary mucinous neoplasms.
    Al-Haddad MA; Friedlin J; Kesterson J; Waters JA; Aguilar-Saavedra JR; Schmidt CM
    HPB (Oxford); 2010 Dec; 12(10):688-95. PubMed ID: 21083794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.
    Mukewar S; de Pretis N; Aryal-Khanal A; Ahmed N; Sah R; Enders F; Larson JJ; Levy MJ; Takahashi N; Topazian M; Pearson R; Vege SS; Chari ST
    Gut; 2017 Oct; 66(10):1811-1817. PubMed ID: 27390303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of pancreatic cancer in patients with pancreatic cyst.
    Munigala S; Gelrud A; Agarwal B
    Gastrointest Endosc; 2016 Jul; 84(1):81-6. PubMed ID: 26524643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of Incidental Intraductal Papillary Mucinous Neoplasms of the Pancreas in Liver Transplant Recipients.
    Dorfman V; Verna EC; Poneros JM; Sethi A; Allendorf JD; Gress FG; Schrope BA; Chabot JA; Gonda TA
    Pancreas; 2016 Apr; 45(4):620-5. PubMed ID: 26495782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic neuroendocrine tumors among patients with intraductal papillary mucinous neoplasms: real association or just a coincidence?
    Gill KR; Scimeca D; Stauffer J; Krishna M; Woodward TA; Jamil LH; Wallace MB; Nguyen JH; Raimondo M
    JOP; 2009 Sep; 10(5):515-7. PubMed ID: 19734627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review.
    Ohno E; Balduzzi A; Hijioka S; De Pastena M; Marchegiani G; Kato H; Takenaka M; Haba S; Salvia R
    Pancreatology; 2024 Feb; 24(1):48-61. PubMed ID: 38161091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal cysts and incidence of pancreatic cancer concomitant with intraductal papillary mucinous neoplasm.
    Ikegawa T; Masuda A; Sakai A; Toyama H; Zen Y; Sofue K; Nakagawa T; Shiomi H; Takenaka M; Kobayashi T; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Azuma T
    Pancreatology; 2018 Jun; 18(4):399-406. PubMed ID: 29685673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
    Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
    Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature and management of pancreatic mucinous cystic neoplasm (MCN): A systematic review of the literature.
    Nilsson LN; Keane MG; Shamali A; Millastre Bocos J; Marijinissen van Zanten M; Antila A; Verdejo Gil C; Del Chiaro M; Laukkarinen J
    Pancreatology; 2016; 16(6):1028-1036. PubMed ID: 27681503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Prevalence of Intraductal Papillary Mucinous Neoplasms in Individuals With BRCA1 and BRCA2 Pathogenic Variant.
    Shah I; Silva-Santisteban A; Germansky KA; Wadhwa V; Tung N; Huang DC; Kandasamy C; Mlabasati J; Bilal M; Sawhney MS
    J Clin Gastroenterol; 2023 Mar; 57(3):317-323. PubMed ID: 35220378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.